BKYI
BIO-key InternationalBKYI
BKYI
About: BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Employees: 52
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
248% more capital invested
Capital invested by funds: $115K [Q4 2024] → $399K (+$284K) [Q1 2025]
13.99% more ownership
Funds ownership: 2.15% [Q4 2024] → 16.14% (+13.99%) [Q1 2025]
0% more funds holding
Funds holding: 13 [Q4 2024] → 13 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Research analyst outlook
We haven’t received any recent analyst ratings for BKYI.
Financial journalist opinion
Neutral
GlobeNewsWire
3 weeks ago
Biometric Identity and Access Management Software Solutions Provider BIO-key Announces Two Webcast Investor Presentations: Aegis Capital Thu. May 22 at 11:30am ET and Maxim Group Wed.
HOLMDEL, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless, Identity-Bound Biometric (IBB) authentication solutions today announces its participation at the Aegis Capital Corp. 2025 Virtual Conference on Thursday, May 22nd and the Maxim Virtual Tech Conference on Wednesday, June 4th – webcast access details provided below.
Neutral
GlobeNewsWire
3 weeks ago
BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East
BIO-key & Cloud Distribution Partner to Expand Advanced Identity Access Management & Biometric Security Solutions Across Middle East via Saudi-based VAR.
Neutral
Seeking Alpha
4 weeks ago
BIO-key International, Inc. (BKYI) Q1 2025 Earnings Call Transcript
BIO-key International, Inc. (NASDAQ:BKYI ) Q1 2025 Earnings Conference Call May 16, 2025 10:00 AM ET Company Participants William Jones - IR Michael DePasquale - Chairman and CEO Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's First Quarter 2025 Conference Call.
Neutral
GlobeNewsWire
1 month ago
BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET
HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25).
Neutral
GlobeNewsWire
1 month ago
BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET
BKYI: BIO-key, Provider of Identity and Access Management Solutions Enhanced with Biometric Authentication Hosts Q1 Investor Call Fri. May 16th at 10am ET.
Neutral
GlobeNewsWire
1 month ago
BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024.
Neutral
Seeking Alpha
2 months ago
BIO-key International, Inc. (BKYI) Q4 2024 Earnings Call Transcript
BIO-key International, Inc. (NASDAQ:BKYI ) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ET Company Participants William Jones - IR Michael DePasquale - Chairman and CEO Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's 2024 Fourth Quarter Conference Call.
Neutral
GlobeNewsWire
2 months ago
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin & Lower Operating Costs, Offsetting 11% Revenue Decrease From Business Transition.
Neutral
GlobeNewsWire
2 months ago
BIO-key Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time
BIO-key (BKYI) Completes Initial Biometric-Based Identity and Access Management Deployment for New International Defense Agency Customer in Record Time.
Neutral
GlobeNewsWire
2 months ago
Identity, Access Management & Biometric Solutions Provider BIO-key International Hosts Q4 Investor Call Thursday, March 27th at 10am ET
Identity, Access Management & Biometric Solutions Provider BIO-key International (Nasdaq: BKYI) Hosts Q4 Investor Call Thursday, March 27th at 10am ET.
Charts implemented using Lightweight Charts™